Fabrication of 3D-Printed Fish-Gelatin-Based Polymer Hydrogel Patches for Local Delivery of PEGylated Liposomal Doxorubicin
3D printing technology has been applied to various fields and its medical applications are expanding. Here, we fabricated implantable 3D bio-printed hydrogel patches containing a nanomedicine as a future tailored cancer treatment. The patches were prepared using a semi-solid extrusion-type 3D biopri...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Marine Drugs |
Subjects: | |
Online Access: | https://www.mdpi.com/1660-3397/18/6/325 |
_version_ | 1797564632274042880 |
---|---|
author | Jin Liu Tatsuaki Tagami Tetsuya Ozeki |
author_facet | Jin Liu Tatsuaki Tagami Tetsuya Ozeki |
author_sort | Jin Liu |
collection | DOAJ |
description | 3D printing technology has been applied to various fields and its medical applications are expanding. Here, we fabricated implantable 3D bio-printed hydrogel patches containing a nanomedicine as a future tailored cancer treatment. The patches were prepared using a semi-solid extrusion-type 3D bioprinter, a hydrogel-based printer ink, and UV-LED exposure. We focused on the composition of the printer ink and semi-synthesized fish gelatin methacryloyl (F-GelMA), derived from cold fish gelatin, as the main component. The low viscosity of F-GelMA due to its low melting point was remarkably improved by the addition of carboxymethyl cellulose sodium (CMC), a pharmaceutical excipient. PEGylated liposomal doxorubicin (DOX), as a model nanomedicine, was incorporated into the hydrogel and liposome stability after photo-polymerization was evaluated. The addition of CMC inhibited particle size increase. Three types of 3D-designed patches (cylinder, torus, gridlines) were produced using a 3D bioprinter. Drug release was dependent on the shape of the 3D-printed patches and UV-LED exposure time. The current study provides useful information for the preparation of 3D printed nanomedicine-based objects. |
first_indexed | 2024-03-10T18:59:48Z |
format | Article |
id | doaj.art-f62d21383dfb48bd98fea7812edadaea |
institution | Directory Open Access Journal |
issn | 1660-3397 |
language | English |
last_indexed | 2024-03-10T18:59:48Z |
publishDate | 2020-06-01 |
publisher | MDPI AG |
record_format | Article |
series | Marine Drugs |
spelling | doaj.art-f62d21383dfb48bd98fea7812edadaea2023-11-20T04:30:02ZengMDPI AGMarine Drugs1660-33972020-06-0118632510.3390/md18060325Fabrication of 3D-Printed Fish-Gelatin-Based Polymer Hydrogel Patches for Local Delivery of PEGylated Liposomal DoxorubicinJin Liu0Tatsuaki Tagami1Tetsuya Ozeki2Drug Delivery and Nano Pharmaceutics, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi 467-8603, JapanDrug Delivery and Nano Pharmaceutics, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi 467-8603, JapanDrug Delivery and Nano Pharmaceutics, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi 467-8603, Japan3D printing technology has been applied to various fields and its medical applications are expanding. Here, we fabricated implantable 3D bio-printed hydrogel patches containing a nanomedicine as a future tailored cancer treatment. The patches were prepared using a semi-solid extrusion-type 3D bioprinter, a hydrogel-based printer ink, and UV-LED exposure. We focused on the composition of the printer ink and semi-synthesized fish gelatin methacryloyl (F-GelMA), derived from cold fish gelatin, as the main component. The low viscosity of F-GelMA due to its low melting point was remarkably improved by the addition of carboxymethyl cellulose sodium (CMC), a pharmaceutical excipient. PEGylated liposomal doxorubicin (DOX), as a model nanomedicine, was incorporated into the hydrogel and liposome stability after photo-polymerization was evaluated. The addition of CMC inhibited particle size increase. Three types of 3D-designed patches (cylinder, torus, gridlines) were produced using a 3D bioprinter. Drug release was dependent on the shape of the 3D-printed patches and UV-LED exposure time. The current study provides useful information for the preparation of 3D printed nanomedicine-based objects.https://www.mdpi.com/1660-3397/18/6/3253D bioprinterfish gelatin methacryloyl (F-GelMA)liposomenanomedicinecontrolled drug release |
spellingShingle | Jin Liu Tatsuaki Tagami Tetsuya Ozeki Fabrication of 3D-Printed Fish-Gelatin-Based Polymer Hydrogel Patches for Local Delivery of PEGylated Liposomal Doxorubicin Marine Drugs 3D bioprinter fish gelatin methacryloyl (F-GelMA) liposome nanomedicine controlled drug release |
title | Fabrication of 3D-Printed Fish-Gelatin-Based Polymer Hydrogel Patches for Local Delivery of PEGylated Liposomal Doxorubicin |
title_full | Fabrication of 3D-Printed Fish-Gelatin-Based Polymer Hydrogel Patches for Local Delivery of PEGylated Liposomal Doxorubicin |
title_fullStr | Fabrication of 3D-Printed Fish-Gelatin-Based Polymer Hydrogel Patches for Local Delivery of PEGylated Liposomal Doxorubicin |
title_full_unstemmed | Fabrication of 3D-Printed Fish-Gelatin-Based Polymer Hydrogel Patches for Local Delivery of PEGylated Liposomal Doxorubicin |
title_short | Fabrication of 3D-Printed Fish-Gelatin-Based Polymer Hydrogel Patches for Local Delivery of PEGylated Liposomal Doxorubicin |
title_sort | fabrication of 3d printed fish gelatin based polymer hydrogel patches for local delivery of pegylated liposomal doxorubicin |
topic | 3D bioprinter fish gelatin methacryloyl (F-GelMA) liposome nanomedicine controlled drug release |
url | https://www.mdpi.com/1660-3397/18/6/325 |
work_keys_str_mv | AT jinliu fabricationof3dprintedfishgelatinbasedpolymerhydrogelpatchesforlocaldeliveryofpegylatedliposomaldoxorubicin AT tatsuakitagami fabricationof3dprintedfishgelatinbasedpolymerhydrogelpatchesforlocaldeliveryofpegylatedliposomaldoxorubicin AT tetsuyaozeki fabricationof3dprintedfishgelatinbasedpolymerhydrogelpatchesforlocaldeliveryofpegylatedliposomaldoxorubicin |